Information in this document is subject to change.
Amendments will be made available by Circassia AB as they occur.
Based on the company’s intellectual property, Circassia develops and commercializes
products for the monitoring of nitric oxide (NO) as a marker of airway inflammation,
to improve the management and care of patients with inflammatory disease in the airways.
Patents:
Circassia’s NIOX products are protected by a number of patents in the US, Europe and a range of other countries.
Circassia AB, Hansellisgatan 13, SE-754 50 Uppsala, Sweden
Phone: +46 8 629 07 80, Fax: +46 8 629 07 81, E-mail: nioxtechsupport@circassia.com
www.niox.com
Copyright 2017 Circassia AB, Uppsala, Sweden.
Circassia is a registered trademark of Circassia Limited
NIOX, NIOX MINO and NIOX VERO are registered trademarks of Circassia AB.